Yüklüyor......
COVID-19 and the neurological disease therapeutic pipeline
From the interruption of clinical trials by shelter-in-place orders to the challenges involved in safely collecting biofluid samples, drug development for neurological disease was hit hard by the COVID-19 pandemic this year. However, the field has responded with innovative solutions, and 2021 could...
Kaydedildi:
| Yayımlandı: | Nat Rev Neurol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747002/ https://ncbi.nlm.nih.gov/pubmed/33340023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00445-w |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|